Bacha K, Chemotti C, Monboisse JC, Robert A, Furlan AL, Smeralda W, Damblon C, Estager J, Brassart-Pasco S, Mbakidi JP, Pršić J, Bouquillon S, Deleu M

Molecules. 2022 11 18;27(22):

Synthesis and Activity of Ionic Antioxidant-Functionalized PAMAMs and PPIs Dendrimers.

Bacha K, Estager J, Brassart-Pasco S, Chemotti C, Fernandes AE, Mbakidi JP, Deleu M, Bouquillon S

Polymers (Basel). 2022 08 27;14(17):

F4, a collagen XIX-derived peptide, inhibits tumor angiogenesis through αvβ3 and α5β1 integrin interaction.

Oudart JB, Villemin M, Brassart B, Sellier C, Terryn C, Dupont-Deshorgue A, Monboisse JC, Maquart FX, Ramont L, Brassart-Pasco S

Cell Adh Migr. 2021 Dec;15(1):215-223

AG-9, an Elastin-Derived Peptide, Increases In Vitro Oral Tongue Carcinoma Cell Invasion, through an Increase in MMP-2 Secretion and MT1-MMP Expression, in a RPSA-Dependent Manner.

Bretaudeau C, Baud S, Dupont-Deshorgue A, Cousin R, Brassart B, Brassart-Pasco S

Biomolecules. 2020 Dec 30;11(1):

Immunotherapy in non-small-cell lung cancer: from targeted molecules to resistance patterns.

Brassart-Pasco S, Dalstein V, Brassart B, Dewolf M, Clavel C, Oudart JB

Pharmacogenomics. 2020 Jun 22;:

Ticagrelor Prevents Endothelial Cell Apoptosis through the Adenosine Signalling Pathway in the Early Stages of Hypoxia.

Feliu C, Peyret H, Brassart-Pasco S, Oszust F, Poitevin G, Nguyen P, Millart H, Djerada Z

Biomolecules. 2020 May 9;10(5):

Angiogenesis Inhibition by a Short 13 Amino Acid Peptide Sequence of Tetrastatin, the α4(IV) NC1 Domain of Collagen IV.

Vautrin-Glabik A, Devy J, Bour C, Baud S, Choulier L, Hoarau A, Dupont-Deshorgue A, Sellier C, Brassart B, Oudart JB, Ramont L, Monboisse JC, Brassart-Pasco S

Front Cell Dev Biol. 2020 ;8:775

Extracellular Vesicle-Dependent Cross-Talk in Cancer-Focus on Pancreatic Cancer.

Nannan L, Oudart JB, Monboisse JC, Ramont L, Brassart-Pasco S, Brassart B

Front Oncol. 2020 ;10:1456

TRPM7/RPSA Complex Regulates Pancreatic Cancer Cell Migration.

Lefebvre T, Rybarczyk P, Bretaudeau C, Vanlaeys A, Cousin R, Brassart-Pasco S, Chatelain D, Dhennin-Duthille I, Ouadid-Ahidouch H, Brassart B, Gautier M

Front Cell Dev Biol. 2020 ;8:549

Tumor Microenvironment: Extracellular Matrix Alterations Influence Tumor Progression.

Brassart-Pasco S, Brézillon S, Brassart B, Ramont L, Oudart JB, Monboisse JC

Front Oncol. 2020 ;10:397

Intratumoral Distribution of YSNSG Cyclopeptide in a Mouse Melanoma Model using Microdialysis.

Slimano F, Djerada Z, Guerin J, Bellouch MI, Brassart-Pasco S, Dukic S

Eur J Pharm Sci. 2019 Dec 19;:105201

Tumour cell blebbing and extracellular vesicle shedding: key role of matrikines and ribosomal protein SA.

Brassart B, Da Silva J, Donet M, Seurat E, Hague F, Terryn C, Velard F, Michel J, Ouadid-Ahidouch H, Monboisse JC, Hinek A, Maquart FX, Ramont L, Brassart-Pasco S

Br. J. Cancer. 2019 Feb 11;:

Conformation-dependent binding of a Tetrastatin peptide to αβ integrin decreases melanoma progression through FAK/PIK/Akt pathway inhibition.

Lambert E, Fuselier E, Ramont L, Brassart B, Dukic S, Oudart JB, Dupont-Deshorgue A, Sellier C, Machado C, Dauchez M, Monboisse JC, Maquart FX, Baud S, Brassart-Pasco S

Sci Rep. 2018 Jun 29;8(1):9837

Age-related modifications of type I collagen impair DDR1-induced apoptosis in non-invasive breast carcinoma cells.

Saby C, Rammal H, Magnien K, Buache E, Brassart-Pasco S, Van-Gulick L, Jeannesson P, Maquoi E, Morjani H

Cell Adh Migr. 2018 Jun 28;:1-13

Structural characterization and pro-tumor properties of a highly conserved matrikine.

Da Silva J, Lameiras P, Beljebbar A, Berquand A, Villemin M, Ramont L, Dukic S, Nuzillard JM, Molinari M, Gautier M, Brassart-Pasco S, Brassart B

Oncotarget. 2018 Apr 3;9(25):17839-17857

First plasma and tissue pharmacokinetic study of the YSNSG cyclopeptide, a new integrin antagonist, using microdialysis.

Slimano F, Djerada Z, Bouchene S, Van Gulick L, Brassart-Pasco S, Dukic S

Eur J Pharm Sci. 2017 May;:

Type XIX collagen: A new partner in the interactions between tumor cells and their microenvironment.

Oudart JB, Monboisse JC, Maquart FX, Brassart B, Brassart-Pasco S, Ramont L

Matrix Biol.. 2017 Jan;57-58:169-177

Aging decreases collagen IV expression in vivo in the dermo-epidermal junction and in vitro in dermal fibroblasts: possible involvement of TGF-β1.

Feru J, Delobbe E, Ramont L, Brassart B, Terryn C, Dupont-Deshorgue A, Garbar C, Monboisse JC, Maquart FX, Brassart-Pasco S

Eur J Dermatol. 2016 Aug;26(4):350-60

Type I collagen aging impairs discoidin domain receptor 2-mediated tumor cell growth suppression.

Saby C, Buache E, Brassart-Pasco S, El Btaouri H, Courageot MP, Van Gulick L, Garnotel R, Jeannesson P, Morjani H

Oncotarget. 2016 May;7(18):24908-27

Design, Synthesis, and Use of MMP-2 Inhibitor-Conjugated Quantum Dots in Functional Biochemical Assays.

Bourguet E, Brazhnik K, Sukhanova A, Moroy G, Brassart-Pasco S, Martin AP, Villena I, Bellon G, Sapi J, Nabiev I

Bioconjug. Chem.. 2016 Apr;27(4):1067-81

The anti-tumor NC1 domain of collagen XIX inhibits the FAK/ PI3K/Akt/mTOR signaling pathway through αvβ3 integrin interaction.

Oudart JB, Doué M, Vautrin A, Brassart B, Sellier C, Dupont-Deshorgue A, Monboisse JC, Maquart FX, Brassart-Pasco S, Ramont L

Oncotarget. 2016 Jan;7(2):1516-28

Investigating the relationship between changes in collagen fiber orientation during skin aging and collagen/water interactions by polarized-FTIR microimaging.

Eklouh-Molinier C, Happillon T, Bouland N, Fichel C, Diebold MD, Angiboust JF, Manfait M, Brassart-Pasco S, Piot O

Analyst. 2015 Jun 29.

A competitive enzyme-linked immunosorbent assay for quantification of tetrastatin in body fluids and tumor extracts.

Dupont-Deshorgue A, Oudart JB, Brassart B, Deslee G, Perotin JM, Diebold MD, Monboisse JC, Ramont L, Brassart-Pasco S

Anal Biochem. 2015 Apr 29. pii: S0003-2697(15)00200-6

Plasmin releases the anti-tumor peptide from the NC1 domain of collagen XIX.

Oudart JB, Brassart-Pasco S, Vautrin A, Sellier C, Machado C, Dupont-Deshorgue A, Brassart B, Baud S, Dauchez M, Monboisse JC, Harakat D, Maquart FX, Ramont L

Oncotarget. 2015 Jan 21.

The DNA hypomethylating agent, 5-aza-2'-deoxycytidine, enhances tumor cell invasion through a transcription-dependent modulation of MMP-1 expression in human fibrosarcoma cells.

Poplineau M, Schnekenburger M, Dufer J, Kosciarz A, Brassart-Pasco S, Antonicelli F, Diederich M, Trussardi-Regnier A

Mol Carcinog. 2015 Jan;54(1):24-34

Matrikines from basement membrane collagens: a new anti-cancer strategy.

Monboisse JC, Oudart JB, Ramont L, Brassart-Pasco S, Maquart FX

Biochim Biophys Acta. 2014 Aug;1840(8):2589-98

Elastin peptides regulate HT-1080 fibrosarcoma cell migration and invasion through an Hsp90-dependent mechanism.

Donet M, Brassart-Pasco S, Salesse S, Maquart FX, Brassart B

Br J Cancer. 2014 Jul 8;111(1):139-48

Changes of skin collagen orientation associated with chronological aging as probed by polarized-FTIR micro-imaging.

Nguyen TT, Eklouh-Molinier C, Sebiskveradze D, Feru J, Terryn C, Manfait M, Brassart-Pasco S, Piot O

Analyst. 2014 May 21;139(10):2482-8

Analytical methods for measuring collagen XIX in human cell cultures, tissue extracts, and biological fluids.

Oudart JB, Brassart-Pasco S, Luczka E, Dupont-Deshorgue A, Bellon G, Boudko SP, Bachinger HP, Monboisse JC, Maquart FX, Ramont L

Anal Biochem. 2013 Jun 15;437(2):111-7

A new anti-tumor strategy based on in vivo tumstatin overexpression after plasmid electrotransfer in muscle.

Thevenard J, Ramont L, Mir LM, Dupont-Deshorgue A, Maquart FX, Monboisse JC, Brassart-Pasco S

Biochem Biophys Res Commun. 2013 Mar 22;432(4):549-52

Characterization of Type I and IV Collagens by Raman Microspectroscopy: Identification of Spectral Markers of the Dermo-Epidermal Junction.

Nguyen TT, Gobinet C, Feru J, Brassart-Pasco S, Manfait M, Piot O

. 2012;27(5-6):421-7.

Tetrastatin, the NC1 domain of the alpha4(IV) collagen chain: a novel potent anti-tumor matrikine.

Brassart-Pasco S, Senechal K, Thevenard J, Ramont L, Devy J, Di Stefano L, Dupont-Deshorgue A, Brezillon S, Feru J, Jazeron JF, Diebold MD, Ricard-Blum S, Maquart FX, Monboisse JC

PLoS One. 2012;7(4):e29587

[Matrikines: a new anticancer therapeutic strategy].

Monboisse JC, Senechal K, Thevenard J, Ramont L, Brassart-Pasco S, Maquart FX

Biol Aujourdhui. 2012;206(2):111-23

The NC1 domain of type XIX collagen inhibits melanoma cell migration.

Toubal A, Ramont L, Terryn C, Brassart-Pasco S, Patigny D, Sapi J, Monboisse JC, Maquart FX

Eur J Dermatol. 2010 Nov-Dec;20(6):712-8

The YSNSG cyclopeptide derived from tumstatin inhibits tumor angiogenesis by down-regulating endothelial cell migration.

Thevenard J, Ramont L, Devy J, Brassart B, Dupont-Deshorgue A, Floquet N, Schneider L, Ouchani F, Terryn C, Maquart FX, Monboisse JC, Brassart-Pasco S

Int J Cancer. 2010 Mar 1;126(5):1055-66.

Ceramide inhibition of MMP-2 expression and human cancer bronchial cell invasiveness involve decreased histone acetylation

Debret R, Brassart-Pasco S, Lorin J, Martoriati A, Deshorgue A, Maquart FX, Hornebeck W, Rahman I, Antonicelli F

Biochim Biophys Acta. 2008 Oct;1783(10):1718-27

An introduction to matrikines: extracellular matrix-derived peptides which regulate cell activity. Implication in tumor invasion.

Maquart FX, Pasco S, Ramont L, Hornebeck W, Monboisse JC

Crit Rev Oncol Hematol. 2004 Mar;49(3):199-202.

Control of melanoma progression by various matrikines from basement membrane macromolecules.

Pasco S, Ramont L, Maquart FX, Monboisse JC

Crit Rev Oncol Hematol. 2004 Mar;49(3):221-33.

Downregulation of BRCA1 in A375 melanoma cell line increases radio-sensitivity and modifies metastatic and angiogenic gene expression.

Hesling C, D'Incan M, D'Incan C, Souteyrand P, Monboisse JC, Pasco S, Madelmont JC, Bignon YJ

J Invest Dermatol. 2004 Feb;122(2):369-80.

The antitumor properties of the alpha3(IV)-(185-203) peptide from the NC1 domain of type IV collagen (tumstatin) are conformation-dependent.

Floquet N, Pasco S, Ramont L, Derreumaux P, Laronze JY, Nuzillard JM, Maquart FX, Alix AJ, Monboisse JC

J Biol Chem. 2004 Jan 16;279(3):2091-100